Back
Health Catalyst 10K Form
Sell
43
HCAT
Health Catalyst
Last Price:
8.26
Seasonality Move:
26.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HCAT News And Ratings
See the #1 stock for the next 7 days that we like better than HCAT
HCAT Financial Statistics
Sales & Book Value
| Annual Sales: | $295.94M |
|---|---|
| Cash Flow: | $1.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.83 |
| Price / Book: | 1.41 |
Profitability
| EPS (TTM): | -1.35000 |
|---|---|
| Net Income (TTM): | $-79.14M |
| Gross Margin: | $131.83M |
| Return on Equity: | -21.76% |
| Return on Assets: | -10.95% |
Health Catalyst Earnings Forecast
Key Health Catalyst Financial Ratios
- The Gross Profit Margin over the past 7 years for HCAT is 44.55%.
- The Selling, General & Administrative Expenses for HCAT have been equal to 48.62% of Gross Profit Margin.
- The Research & Development expenses have been 24.54% of Revenue.
- The Interest Expense is -6.17% of Operating Income.
- The Net Earning history of HCAT is -39.92% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Health Catalyst Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | HCAT |
| CUSIP: | 42225T |
| Website: | healthcatalyst.com |
Debt
| Debt-to-Equity Ratio: | 0.97 |
|---|---|
| Current Ratio: | 1.41 |
| Quick Ratio: | 1.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 17.74 |
HCAT Technical Analysis vs Fundamental Analysis
Sell
43
Health Catalyst (HCAT)
is a Sell
Is Health Catalyst a Buy or a Sell?
-
Health Catalyst stock is rated a Sell
The current Health Catalyst [HCAT] share price is $8.24. The Score for HCAT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.